home / stock / snss / snss news


SNSS News and Press, Viracta Therapeutics Inc Com From 01/18/21

Stock Information

Company Name: Viracta Therapeutics Inc Com
Stock Symbol: SNSS
Market: NASDAQ

Menu

SNSS SNSS Quote SNSS Short SNSS News SNSS Articles SNSS Message Board
Get SNSS Alerts

News, Short Squeeze, Breakout and More Instantly...

SNSS - Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch In January

Biotech Penny Stocks For Your January Watch List Last week was a wild one for penny stocks and blue-chip stocks alike. While we saw more action in smaller companies, both the Russell 2000 Small-Cap ETF ( IWM ) and the S&P 500 ETF ( SPY ) pulled back. One of the b...

SNSS - MERGER INVESTIGATION: Halper Sadeh LLP Investigates CPAH, HMSY, SNSS, EIDX; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CounterPath Corporation (NASDAQ:CPAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary...

SNSS - Microcaps mostly among premarket gainers

Prevail Therapeutics (PRVL) +84% on being acquired by Lilly for ~$1.04B.OncoCyte Corporation (OCX) +63% after company enters agreement with Burning Rock Biotech.Anavex Life Sciences (AVXL) +40% as it's blarcamesine successful in mid-stage rett syndrome study.Mid-Con Energy Part...

SNSS - Sunesis rises 1.9% after Viracta sees registration trial in H1 for lymphoma regimen

Sunesis Pharmaceuticals (SNSS) gains 1.9% in early trading after Viracta Therapeutics, the company Sunesis has agreed to acquire, reports complete responses were observed across multiple  EBV+ lymphoma subtypes in a Phase 2 trial investigating an oral regimen of ...

SNSS - Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA

Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA SAN DIEGO , Dec. 7, 2020 /PRNewswire/ -- Viracta Therapeutics, Inc. (Viracta or the Company), a precision onco...

SNSS - ALERT: Halper Sadeh LLP Encourages INFO, SNSS, and WORK Shareholders to Contact the Firm

NEW YORK, NY / ACCESSWIRE / December 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: IHS Markit Ltd. (NYSE:INFO) concerning potential violations of law relating to its sale to S&P Global Inc. Under the terms of t...

SNSS - Zoom Video Communications, CureVac leads premarket losers' pack

Titan Pharmaceuticals (TTNP) -15%.Tuniu TOUR -15% on Q3 earnings release.Medigus MDGS -15% on appointment of new finance chief at MedigusECMOHO MOHO -14% on Q3 earnings release.Minerva Neurosciences (NERV) -14% after announcing outcome of Type C meeting with...

SNSS - Top Penny Stocks To Watch Today; 4 With 75%-233% Price Targets

Are These On Your List Of Penny Stocks To Buy Or Avoid Right Now? Are penny stocks on your list heading into December? If not, you might want to consider a few things right now. First, small-cap stocks have been on fire in November. The Russell 2000 ETF – IWM , has far ou...

SNSS - MRNA, GME, GNW and QS among premarket gainers

Sunesis Pharmaceuticals (SNSS) +50% after announcing merger agreement with Viracta Therapeutics.China Automotive Systems (CAAS) +32% on guiding 2021 sales boom.India Globalization Capital (IGC) +24%.Ameri Holdings (AMRH) +26%.Oramed Pharmaceuticals (ORMP) +24%.Navios ...

SNSS - Sunesis Pharma to merge with Viracta Therapeutics in all-stock deal

Sunesis Pharmaceuticals (SNSS) soars 48% in premarket, after announcing a reverse merger agreement with a privately-held Viracta Therapeutics. The new organization will do business under the Viracta moniker and intends to be listed on the Nasdaq under the ticker symbo...

Previous 10 Next 10